• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌转录因子:炎症相关胰腺发生癌变的基石。

Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis.

机构信息

Signaling and Transcription Laboratory, Department of Gastroenterology, Philipps-University of Marburg, Marburg, Germany.

出版信息

Gut. 2013 Feb;62(2):310-6. doi: 10.1136/gutjnl-2011-301008. Epub 2011 Oct 13.

DOI:10.1136/gutjnl-2011-301008
PMID:21997559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539739/
Abstract

Transcription factors are proteins that regulate gene expression by modulating the synthesis of messenger RNA. Since this process is often one dominant control point in the production of many proteins, transcription factors represent the key regulators of numerous cellular functions, including proliferation, differentiation and apoptosis. Pancreatic cancer progression is characterised by activation of inflammatory signalling pathways converging on a limited set of transcription factors that fine-tune gene expression patterns contributing to the growth and maintenance of these tumours. Thus strategies targeting these transcriptional networks activated in pancreatic cancer cells could block the effects of upstream inflammatory responses participating in pancreatic tumorigenesis. The authors review this field of research and summarise current strategies for targeting oncogenic transcription factors and their activating signalling networks in the treatment of pancreatic cancer.

摘要

转录因子是通过调节信使 RNA 的合成来调节基因表达的蛋白质。由于这个过程通常是许多蛋白质产生的一个主要控制点,转录因子是许多细胞功能的关键调节剂,包括增殖、分化和凋亡。胰腺癌的进展的特点是炎症信号通路的激活,这些信号通路汇聚到一组有限的转录因子上,这些转录因子微调基因表达模式,有助于这些肿瘤的生长和维持。因此,针对这些在胰腺癌细胞中激活的转录网络的策略可以阻断参与胰腺肿瘤发生的上游炎症反应的影响。作者回顾了这一研究领域,并总结了目前针对致癌转录因子及其激活信号网络的治疗胰腺癌的策略。

相似文献

1
Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis.致癌转录因子:炎症相关胰腺发生癌变的基石。
Gut. 2013 Feb;62(2):310-6. doi: 10.1136/gutjnl-2011-301008. Epub 2011 Oct 13.
2
Fundamentals of transcription factors and their impact on pancreatic development and cancer.
Pancreatology. 2003;3(4):276-83. doi: 10.1159/000071765.
3
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.致癌性 Kras 基因对于小鼠胰腺癌细胞的起始和维持都是必需的。
J Clin Invest. 2012 Feb;122(2):639-53. doi: 10.1172/JCI59227. Epub 2012 Jan 9.
4
The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.黏蛋白MUC4是胰腺癌中K-ras癌基因的转录和转录后靶点。MAPK/AP-1、NF-κB和RalB信号通路的影响。
Biochim Biophys Acta. 2015 Dec;1849(12):1375-84. doi: 10.1016/j.bbagrm.2015.10.014. Epub 2015 Oct 22.
5
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.YAP1和TAZ通过直接上调JAK-STAT3信号通路来控制小鼠胰腺癌的起始。
Gastroenterology. 2016 Sep;151(3):526-39. doi: 10.1053/j.gastro.2016.05.006. Epub 2016 May 20.
6
An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.致癌性KRAS转录程序激活RHOGEF ARHGEF2,以介导胰腺癌的转化表型。
Oncotarget. 2017 Jan 17;8(3):4484-4500. doi: 10.18632/oncotarget.13152.
7
YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.YEATS4通过激活β-连环蛋白/TCF信号通路促进胰腺癌的肿瘤发生。
Oncotarget. 2017 Apr 11;8(15):25200-25210. doi: 10.18632/oncotarget.15633.
8
Transcriptional control of gene expression in pancreatic cancer: from sequence-specific transcription factors to nuclear architecture.胰腺癌中基因表达的转录调控:从序列特异性转录因子到核结构
J Gastrointest Cancer. 2011 Jun;42(2):73-5. doi: 10.1007/s12029-011-9254-4.
9
RAS oncogenic signal upregulates EZH2 in pancreatic cancer.RAS 致癌信号上调胰腺癌中的 EZH2。
Biochem Biophys Res Commun. 2012 Jan 20;417(3):1074-9. doi: 10.1016/j.bbrc.2011.12.099. Epub 2011 Dec 26.
10
NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.NFATc1将表皮生长因子受体(EGFR)信号传导与胰腺中Sox9转录的诱导及腺泡-导管转分化联系起来。
Gastroenterology. 2015 May;148(5):1024-1034.e9. doi: 10.1053/j.gastro.2015.01.033. Epub 2015 Jan 23.

引用本文的文献

1
Identification of Common miRNAs Differentially Expressed in Periodontitis and Pancreatic Cancer.牙周炎和胰腺癌中差异表达的常见微小RNA的鉴定
In Vivo. 2025 May-Jun;39(3):1422-1439. doi: 10.21873/invivo.13944.
2
Fine-Tuning of ATF4 DNA Binding Activity by a Secondary Basic Motif Unique to the ATF-X Subfamily of bZip Transcription Factors.通过bZip转录因子ATF-X亚家族特有的二级碱性基序对ATF4 DNA结合活性进行微调。
Biochemistry. 2025 Mar 18;64(6):1257-1265. doi: 10.1021/acs.biochem.4c00640. Epub 2025 Feb 24.
3
High Systemic Immune-Inflammation Index Values Before Treatment Predict Poor Pancreatic Cancer Outcomes After Definitive Chemoradiotherapy.治疗前高全身免疫炎症指数值预示着确定性放化疗后胰腺癌预后不良。
Clin Med Insights Oncol. 2024 Nov 7;18:11795549241298552. doi: 10.1177/11795549241298552. eCollection 2024.
4
Methylation patterns associated with C-reactive protein in racially and ethnically diverse populations.与不同种族和民族人群中 C 反应蛋白相关的甲基化模式。
Epigenetics. 2024 Dec;19(1):2333668. doi: 10.1080/15592294.2024.2333668. Epub 2024 Apr 3.
5
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.新型 Ref-1/APE1 靶向抑制剂在多种癌症类型的临床应用中显示出更高的效力。
Pharmacol Res. 2024 Mar;201:107092. doi: 10.1016/j.phrs.2024.107092. Epub 2024 Feb 2.
6
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.肥胖和糖尿病相关的胰腺癌发病机制:全面系统的综述。
Signal Transduct Target Ther. 2023 Mar 24;8(1):139. doi: 10.1038/s41392-023-01376-w.
7
Associations between Systemic Immune-Inflammation Index and Diabetes Mellitus Secondary to Pancreatic Ductal Adenocarcinoma.全身免疫炎症指数与胰腺导管腺癌继发糖尿病之间的关联。
J Clin Med. 2023 Jan 18;12(3):756. doi: 10.3390/jcm12030756.
8
-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer.胰腺癌中依赖状态的致癌性EZH2活性
Cancers (Basel). 2022 Jul 15;14(14):3451. doi: 10.3390/cancers14143451.
9
Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer.NFATc1 和 EZH2 在胰腺癌中的染色质非依赖性相互作用。
Cells. 2021 Dec 8;10(12):3463. doi: 10.3390/cells10123463.
10
Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan.循环炎症标志物与胰腺癌风险:日本的一项前瞻性病例-队列研究。
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):236-241. doi: 10.1158/1055-9965.EPI-21-0808. Epub 2021 Oct 25.

本文引用的文献

1
Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.白细胞介素 6 转染信号通过 Stat3/Socs3 的激活促进胰腺上皮内瘤变的进展和胰腺癌的发生。
Cancer Cell. 2011 Apr 12;19(4):456-69. doi: 10.1016/j.ccr.2011.03.009.
2
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.Stat3 和 MMP7 有助于胰腺导管腺癌的发生和进展。
Cancer Cell. 2011 Apr 12;19(4):441-55. doi: 10.1016/j.ccr.2011.03.002.
3
GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment.GLI2 转录因子介导肿瘤微环境中的细胞因子串扰。
J Biol Chem. 2011 Jun 17;286(24):21524-34. doi: 10.1074/jbc.M111.234146. Epub 2011 Mar 18.
4
Tumor microenvironment and progression of pancreatic cancer.肿瘤微环境与胰腺癌的进展
Exp Oncol. 2010 Sep;32(3):128-31.
5
Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.吉西他滨联合Src 激酶和表皮生长因子受体阻断克服 STAT3 介导的胰腺肿瘤生长抑制耐药性。
Clin Cancer Res. 2011 Feb 1;17(3):483-93. doi: 10.1158/1078-0432.CCR-10-1670. Epub 2011 Jan 25.
6
NF-κB and STAT3 - key players in liver inflammation and cancer.NF-κB 和 STAT3 - 肝脏炎症和癌症的关键参与者。
Cell Res. 2011 Jan;21(1):159-68. doi: 10.1038/cr.2010.183. Epub 2010 Dec 28.
7
Hedgehog signaling and therapeutics in pancreatic cancer.刺猬信号通路与胰腺癌治疗。
Carcinogenesis. 2011 Apr;32(4):445-51. doi: 10.1093/carcin/bgq280. Epub 2010 Dec 24.
8
Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer.合成三萜延长胰腺癌转基因小鼠模型的生存期。
Cancer Prev Res (Phila). 2010 Nov;3(11):1427-34. doi: 10.1158/1940-6207.CAPR-10-0197. Epub 2010 Oct 19.
9
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.KRAS、Hedgehog、Wnt 与胰腺导管腺癌扭曲的发育生物学。
Nat Rev Cancer. 2010 Oct;10(10):683-95. doi: 10.1038/nrc2899. Epub 2010 Sep 3.
10
NFAT, immunity and cancer: a transcription factor comes of age.NFAT、免疫与癌症:一个成熟的转录因子
Nat Rev Immunol. 2010 Sep;10(9):645-56. doi: 10.1038/nri2818. Epub 2010 Aug 20.